Affiliations 

  • 1 School of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil
  • 2 Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa
  • 3 International Society of Nephrology, Brussels, Belgium
  • 4 Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia
  • 5 Nephrology Department, Alqassimi Hospital, Sharjah, United Arab Emirates
  • 6 Division of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • 7 Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA
  • 8 UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK
  • 9 NxStage Medical, Inc., Lawrence, Massachusetts, USA
  • 10 Unidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México
  • 11 University of Leicester, Leicester, UK
  • 12 Department of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia
  • 13 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands
  • 14 Division of Nephrology, The University of Tokyo School of Medicine, Hongo, Japan
  • 15 Department of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh
  • 16 Department of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India
  • 17 Department of Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
  • 18 Dialysis Unit, Centro Asistencial del Sindicato Médico del Uruguay Institución de Asistencia Médica Privada de Profesionales Sin Fines de lucro, Montevideo, Uruguay
  • 19 Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey
  • 20 Department of Medicine, University of Otago, Dunedin, New Zealand
  • 21 Medical Affairs, Baxter Healthcare, Guangzhou, China
  • 22 Division of Nephrology, Guangdong Provincial People's School of Medicine, South China University of Technology, Guangzhou, China
  • 23 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China
  • 24 Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia
Kidney Int Suppl (2011), 2020 Mar;10(1):e3-e9.
PMID: 32149004 DOI: 10.1016/j.kisu.2019.11.001

Abstract

A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.